These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 1700753

  • 1. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin.
    Wicker LS, Boltz RC, Matt V, Nichols EA, Peterson LB, Sigal NH.
    Eur J Immunol; 1990 Oct; 20(10):2277-83. PubMed ID: 1700753
    [Abstract] [Full Text] [Related]

  • 2. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH.
    J Immunol; 1990 Jan 01; 144(1):251-8. PubMed ID: 1688572
    [Abstract] [Full Text] [Related]

  • 3. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
    Dumont FJ, Melino MR, Staruch MJ, Koprak SL, Fischer PA, Sigal NH.
    J Immunol; 1990 Feb 15; 144(4):1418-24. PubMed ID: 1689353
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE, Kromwel L, Doe SE, Denyer M.
    Immunology; 1991 Apr 15; 72(4):544-9. PubMed ID: 1709916
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells.
    Metcalfe SM, Richards FM.
    Transplantation; 1990 Apr 15; 49(4):798-802. PubMed ID: 1691537
    [Abstract] [Full Text] [Related]

  • 6. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
    Bierer BE, Schreiber SL, Burakoff SJ.
    Eur J Immunol; 1991 Feb 15; 21(2):439-45. PubMed ID: 1705513
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA, Bird IA, Almawi WY, Rieder MJ.
    J Pharmacol Exp Ther; 1997 Apr 15; 281(1):540-8. PubMed ID: 9103542
    [Abstract] [Full Text] [Related]

  • 9. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S, Suzuki G, Kawase Y, Takaku F.
    J Immunol; 1987 Sep 15; 139(6):1797-803. PubMed ID: 2442255
    [Abstract] [Full Text] [Related]

  • 10. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ, Michielsen EC, Verstappen J, Fasse E, Joosten I.
    Transplantation; 2003 May 15; 75(9):1581-90. PubMed ID: 12792519
    [Abstract] [Full Text] [Related]

  • 11. A role for calcineurin in degranulation of murine cytotoxic T lymphocytes.
    Dutz JP, Fruman DA, Burakoff SJ, Bierer BE.
    J Immunol; 1993 Apr 01; 150(7):2591-8. PubMed ID: 7681074
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity.
    Nelson PA, Akselband Y, Kawamura A, Su M, Tung RD, Rich DH, Kishore V, Rosborough SL, DeCenzo MT, Livingston DJ.
    J Immunol; 1993 Mar 15; 150(6):2139-47. PubMed ID: 7680683
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
    Tocci MJ, Matkovich DA, Collier KA, Kwok P, Dumont F, Lin S, Degudicibus S, Siekierka JJ, Chin J, Hutchinson NI.
    J Immunol; 1989 Jul 15; 143(2):718-26. PubMed ID: 2472451
    [Abstract] [Full Text] [Related]

  • 15. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N, Lucas JJ, Szepesi A, Franklin RA, Domenico J, Gelfand EW.
    J Cell Physiol; 1993 Jan 15; 154(1):7-15. PubMed ID: 8419408
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
    Ryffel B, Weber E, Mihatsch MJ.
    Exp Nephrol; 1994 Jan 15; 2(6):324-33. PubMed ID: 7532090
    [Abstract] [Full Text] [Related]

  • 18. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
    de Paulis A, Cirillo R, Ciccarelli A, Condorelli M, Marone G.
    J Immunol; 1991 Apr 01; 146(7):2374-81. PubMed ID: 1706398
    [Abstract] [Full Text] [Related]

  • 19. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
    Fruman DA, Wood MA, Gjertson CK, Katz HR, Burakoff SJ, Bierer BE.
    Eur J Immunol; 1995 Feb 01; 25(2):563-71. PubMed ID: 7533090
    [Abstract] [Full Text] [Related]

  • 20. Effects of cyclosporin A on the immune system of the mouse. I. Evidence for a direct selective effect of cyclosporin A on B cells responding to anti-immunoglobulin antibodies.
    Dongworth DW, Klaus GG.
    Eur J Immunol; 1982 Dec 01; 12(12):1018-22. PubMed ID: 6819147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.